Last reviewed · How we verify

NCT04945798

Effects of Osteopathic Manipulative Treatment of Fascial Restrictions on Body Awareness, Mood, and Proprioception

Completed NA Last updated 29 April 2022
What this trial tests

NA trial testing OMT in Segmental and Somatic Dysfunction of Other Regions (M99.09) in 29 participants. Completed in 15 March 2022.

Timeline
22 March 2021
Primary endpoint
15 March 2022
15 March 2022

Quick facts

Lead sponsorNew York Institute of Technology
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment29
Start date22 March 2021
Primary completion15 March 2022
Estimated completion15 March 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

New York Institute of Technology

Who can join

Adults 18 to 65, any sex, with Segmental and Somatic Dysfunction of Other Regions (M99.09). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research is to assess the effects osteopathic manipulative treatment (OMT) of fascial strain patterns on body awareness, proprioception, and mood.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of OMT

Trials testing the same drug.

Other New York Institute of Technology trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04945798.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing